KR930007902A - 아세틸렌 화합물 - Google Patents
아세틸렌 화합물 Download PDFInfo
- Publication number
- KR930007902A KR930007902A KR1019920019620A KR920019620A KR930007902A KR 930007902 A KR930007902 A KR 930007902A KR 1019920019620 A KR1019920019620 A KR 1019920019620A KR 920019620 A KR920019620 A KR 920019620A KR 930007902 A KR930007902 A KR 930007902A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- methyl
- alk
- general formula
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- -1 Acetylene compound Chemical class 0.000 title 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 30
- 150000003839 salts Chemical group 0.000 claims abstract 21
- 125000003545 alkoxy group Chemical group 0.000 claims abstract 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract 6
- 125000000217 alkyl group Chemical group 0.000 claims abstract 5
- 125000002947 alkylene group Chemical group 0.000 claims abstract 5
- 125000001118 alkylidene group Chemical group 0.000 claims abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 5
- 239000001257 hydrogen Substances 0.000 claims abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 5
- 238000000034 method Methods 0.000 claims abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract 3
- 125000004423 acyloxy group Chemical group 0.000 claims abstract 2
- 208000026935 allergic disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 claims 1
- 150000002440 hydroxy compounds Chemical class 0.000 claims 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH03135/91-8 | 1991-10-25 | ||
| CH313591 | 1991-10-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR930007902A true KR930007902A (ko) | 1993-05-20 |
Family
ID=4249377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019920019620A Withdrawn KR930007902A (ko) | 1991-10-25 | 1992-10-24 | 아세틸렌 화합물 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5248693A (enExample) |
| EP (1) | EP0539329A1 (enExample) |
| JP (1) | JPH05221980A (enExample) |
| KR (1) | KR930007902A (enExample) |
| AU (1) | AU2723292A (enExample) |
| CA (1) | CA2081262A1 (enExample) |
| FI (1) | FI924768L (enExample) |
| HU (1) | HUT65627A (enExample) |
| IL (1) | IL103524A0 (enExample) |
| MX (1) | MX9206127A (enExample) |
| NO (1) | NO924112L (enExample) |
| TW (1) | TW207531B (enExample) |
| ZA (1) | ZA928201B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2072125T3 (es) * | 1991-10-25 | 1995-07-01 | Ciba Geigy Ag | Procedimiento para la obtencion de indoles substituidos. |
| US5439929A (en) * | 1994-03-01 | 1995-08-08 | Pfizer Inc. | Bicyclic carbamates, pharmaceutical compositions and use |
| GB9804648D0 (en) | 1998-03-06 | 1998-04-29 | Zeneca Ltd | Chemical compounds |
| GB9805520D0 (en) * | 1998-03-17 | 1998-05-13 | Zeneca Ltd | Chemical compounds |
| GB9811427D0 (en) | 1998-05-29 | 1998-07-22 | Zeneca Ltd | Chemical compounds |
| ES2273725T3 (es) | 1999-09-04 | 2007-05-16 | Astrazeneca Ab | Derivados de hidroxiacetamidobencenosulfonamida. |
| ES2307528T3 (es) | 1999-09-04 | 2008-12-01 | Astrazeneca Ab | Amidas como inhibidores para la piruvato deshidrogenasa. |
| ES2216940T3 (es) | 1999-09-04 | 2004-11-01 | Astrazeneca Ab | Derivados n-fenilicos de 2-hidroxi-2-metil-3,3,3-trifluoropropanamida sustituidos que elevan la actividad de piruvato deshidrogenasa. |
| GB0120471D0 (en) * | 2001-08-23 | 2001-10-17 | Astrazeneca Ab | Chemical compounds |
| EP2981324B1 (en) * | 2013-04-05 | 2020-01-01 | Miller, Leonard B. | Methods and articles of manufacture for the treatment of skin |
| CN108084077B (zh) * | 2017-12-20 | 2020-04-14 | 江汉大学 | 一种扎鲁司特中间体的合成方法 |
| CN112516080B (zh) * | 2018-01-23 | 2023-09-19 | 盛元医药广州有限公司 | 一种眼用药物组合物及其制备方法和应用 |
| CN115458713B (zh) * | 2022-10-21 | 2024-04-19 | 深圳市山木新能源科技股份有限公司 | 一种聚阴离子钠离子电池电极 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607294D0 (en) * | 1985-04-17 | 1986-04-30 | Ici America Inc | Heterocyclic amide derivatives |
| DK496086A (da) * | 1985-10-17 | 1987-04-18 | Ici America Inc | Heterocykliske forbindelser |
| GB8623429D0 (en) * | 1985-10-17 | 1986-11-05 | Ici America Inc | Carboximide derivatives |
| GB8906032D0 (en) * | 1988-04-14 | 1989-04-26 | Ici America Inc | Hetera-aliphatic carboxamides |
| DE59103389D1 (de) * | 1990-05-04 | 1994-12-08 | Ciba Geigy Ag | Substituierte Indole. |
-
1992
- 1992-10-16 EP EP92810795A patent/EP0539329A1/de not_active Ceased
- 1992-10-21 AU AU27232/92A patent/AU2723292A/en not_active Abandoned
- 1992-10-21 FI FI924768A patent/FI924768L/fi not_active Application Discontinuation
- 1992-10-21 US US07/964,184 patent/US5248693A/en not_active Expired - Fee Related
- 1992-10-22 TW TW081108422A patent/TW207531B/zh active
- 1992-10-22 HU HU9203343A patent/HUT65627A/hu unknown
- 1992-10-23 ZA ZA928201A patent/ZA928201B/xx unknown
- 1992-10-23 IL IL103524A patent/IL103524A0/xx unknown
- 1992-10-23 MX MX9206127A patent/MX9206127A/es unknown
- 1992-10-23 NO NO92924112A patent/NO924112L/no unknown
- 1992-10-23 CA CA002081262A patent/CA2081262A1/en not_active Abandoned
- 1992-10-23 JP JP4286027A patent/JPH05221980A/ja active Pending
- 1992-10-24 KR KR1019920019620A patent/KR930007902A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| TW207531B (enExample) | 1993-06-11 |
| US5248693A (en) | 1993-09-28 |
| FI924768A0 (fi) | 1992-10-21 |
| HU9203343D0 (en) | 1992-12-28 |
| IL103524A0 (en) | 1993-03-15 |
| FI924768A7 (fi) | 1993-04-26 |
| AU2723292A (en) | 1993-04-29 |
| NO924112L (no) | 1993-04-26 |
| JPH05221980A (ja) | 1993-08-31 |
| CA2081262A1 (en) | 1993-04-26 |
| EP0539329A1 (de) | 1993-04-28 |
| MX9206127A (es) | 1993-08-01 |
| FI924768L (fi) | 1993-04-26 |
| HUT65627A (en) | 1994-07-28 |
| ZA928201B (en) | 1993-04-28 |
| NO924112D0 (no) | 1992-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR930007902A (ko) | 아세틸렌 화합물 | |
| KR880006193A (ko) | 피페리딘 화합물 및 그의 제조 및 용도 | |
| KR910016931A (ko) | 과콜레스테린혈증 치료제 | |
| KR880003958A (ko) | 신규 세펨화합물 및 그의 제조방법 | |
| EP0632036A3 (en) | Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | |
| AU8528291A (en) | Leukotriene b4 antagonists | |
| KR880007514A (ko) | 키놀린 화합물 | |
| ES2132135T3 (es) | Procedimiento para la preparacion de compuestos de tiazolidina u oxazolidina farmaceuticamente activos mediante una reductasa de levadura. | |
| KR930005972A (ko) | N-알킬-3-페닐-3-(2-알킬티오페녹시)프로필아민 | |
| KR900006296A (ko) | 이미다졸린 유도체 및 그의 제조방법 | |
| AU3453493A (en) | Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections | |
| KR920017669A (ko) | 갈륨 화합물 | |
| KR880001677A (ko) | β-락탐 화합물, 그의 제조 방법, 이를 함유하는 세균 감염성 질병 치료용 약제 및 그의 합성을 위한 중간체 | |
| KR900014406A (ko) | 세펨 화합물 및 이의 제조방법 | |
| KR930007914A (ko) | 제1위치에 에테르 또는 티오에테르 그룹을 함유하는 프탈라진 및 이의 제조방법 | |
| KR890000482A (ko) | (8β)-1-알킬-6-(치환된) 에르 골린의 시클로알킬아미드 | |
| CA2066304A1 (en) | Pharmaceutical composition for the treatment of autoimmune diseases | |
| KR920002517A (ko) | 칼모둘린 억제 특성을 갖는 벤즈히드릴 유도체 및 그의 제조방법 | |
| KR910000748A (ko) | 결정성 세펨산 부가염 및 이의 제조 방법 | |
| KR940011466A (ko) | 피롤유도체, 이것의 제법 및 치료에의 이용 | |
| KR890003755A (ko) | 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물 | |
| KR850000415A (ko) | 퀴나졸리논 유도체의 제조방법 | |
| KR940005621A (ko) | 벤조[b]티오펜-3-일-피페라진. 이의 제조방법 및 약제로서 이의 용도 | |
| KR940021524A (ko) | 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법 | |
| AU1174383A (en) | Method for modulating the immune response with dibenzocycloheptenylidenes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19921024 |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |